Overview
- The Dubai Authority for Healthy Longevity, which launched on Wednesday, June 10, will be chaired by Crown Prince Sheikh Hamdan bin Mohammed and was announced by Ruler Sheikh Mohammed bin Rashid.
- The authority’s mandate is to build a science-driven, risk‑proportionate regulatory framework for longevity therapies and technologies and to coordinate activity across research, clinical trials, manufacturing and treatment delivery.
- Dubai officials link the move directly to the Dubai Economic Agenda (D33), saying the body will attract investment, industrial capability and specialised talent to create a local market for advanced therapeutics.
- Coverage so far outlines strategic goals and partnerships with Dubai Health Authority, Dubai Health, Dubai Municipality and Dubai Future Foundation but provides no published budget, detailed governance beyond the chair, or implementation timetable.
- Reporters note the launch responds to healthspan challenges—WHO data cited by outlets put healthy life expectancy in the UAE at about 66 years—and officials say the authority aims to shift care toward prevention and reduce long‑term costs by drawing trials, tech and talent to Dubai.